Get started
InMed Pharmaceuticals Inc.InMed Pharmaceuticals Inc.InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc.

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsForecastsSeasonals
Full chart
Full chart

Compare with InMed Pharmaceuticals Inc.



Key stats


Market capitalization
‪7.58 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−3.12 USD
Net income (FY)
‪−12.56 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪4.08 M‬
Beta (1Y)
2.35

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Employees


Employees (FY)
6
Change (1Y)
−7−53.85%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−1.90 M‬ USD

Company info


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Eric A. Adams
Website
inmedpharma.com
Headquarters
Vancouver
Founded
1981
IPO date
Nov 12, 2020
ISIN
CA4576377002
CUSIP
457637700
FIGI
BBG000BT4589
Identifiers
ISIN CA4576377002
CFI code
ESVUFR
InMed Pharmaceuticals, Inc. is a pharmaceutical drug development company, which engages in developing small molecule drug candidates that are preferential signaling ligands of the endogenous CB1 and CB2 receptors as well as other receptor targets linked to human disease. The company was founded by Christopher Bogart, Sazzad Hossain, Hyder A. Khoja, and Craig D. Schneider on May 19, 1981 and is headquartered in Vancouver, Canada.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
Oscillators
Neutral
Summary
Neutral
Summary
Neutral
Summary
Neutral
Moving Averages
Neutral
Moving Averages
Neutral

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently asked questions


The current price of INM is 1.38 USD — it has decreased by −1.43% in the past 24 hours. Watch InMed Pharmaceuticals Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange InMed Pharmaceuticals Inc. stocks are traded under the ticker INM.
INM stock has fallen by −0.72% compared to the previous week, the month change is a −6.76% fall, over the last year InMed Pharmaceuticals Inc. has showed a −35.81% decrease.
INM reached its all-time high on Jan 8, 2018 with the price of 32,178.22 USD, and its all-time low was 0.57 USD and was reached on Mar 31, 2026. View more price dynamics on INM chart.
See other stocks reaching their highest and lowest prices.
INM stock is 3.70% volatile and has beta coefficient of 2.35. Track InMed Pharmaceuticals Inc. stock price on the chart and check out the list of the most volatile stocks — is InMed Pharmaceuticals Inc. there?
Today InMed Pharmaceuticals Inc. has the market capitalization of ‪7.58 M‬, it has increased by 4.62% over the last week.
Yes, you can track InMed Pharmaceuticals Inc. financials in yearly and quarterly reports right on TradingView.
InMed Pharmaceuticals Inc. is going to release the next earnings report on Nov 6, 2026. Keep track of upcoming events with our Earnings Calendar.
INM net income for the last quarter is ‪−5.84 M‬ USD, while the quarter before that showed ‪−2.97 M‬ USD of net income which accounts for 0.00% change. Track more InMed Pharmaceuticals Inc. financial stats to get the full picture.
No, INM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 28, 2026, the company has 6 employees. See our rating of the largest employees — is InMed Pharmaceuticals Inc. on this list?
Like other stocks, INM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade InMed Pharmaceuticals Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So InMed Pharmaceuticals Inc. technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating InMed Pharmaceuticals Inc. stock shows the sell signal. See more of InMed Pharmaceuticals Inc. technicals for a more comprehensive analysis.